K. Dadson Et Al. , "Statins Protect Against Early Stages of Doxorubicin-induced Cardiotoxicity Through the Regulation of Akt Signaling and SERCA2," CJC Open , vol.4, no.12, pp.1043-1052, 2022
Dadson, K. Et Al. 2022. Statins Protect Against Early Stages of Doxorubicin-induced Cardiotoxicity Through the Regulation of Akt Signaling and SERCA2. CJC Open , vol.4, no.12 , 1043-1052.
Dadson, K., Thavendiranathan, P., Hauck, L., Grothe, D., Azam, M. A., Stanley-Hasnain, S., ... Mahiny-Shahmohammady, D.(2022). Statins Protect Against Early Stages of Doxorubicin-induced Cardiotoxicity Through the Regulation of Akt Signaling and SERCA2. CJC Open , vol.4, no.12, 1043-1052.
Dadson, Keith Et Al. "Statins Protect Against Early Stages of Doxorubicin-induced Cardiotoxicity Through the Regulation of Akt Signaling and SERCA2," CJC Open , vol.4, no.12, 1043-1052, 2022
Dadson, Keith Et Al. "Statins Protect Against Early Stages of Doxorubicin-induced Cardiotoxicity Through the Regulation of Akt Signaling and SERCA2." CJC Open , vol.4, no.12, pp.1043-1052, 2022
Dadson, K. Et Al. (2022) . "Statins Protect Against Early Stages of Doxorubicin-induced Cardiotoxicity Through the Regulation of Akt Signaling and SERCA2." CJC Open , vol.4, no.12, pp.1043-1052.
@article{article, author={Keith Dadson Et Al. }, title={Statins Protect Against Early Stages of Doxorubicin-induced Cardiotoxicity Through the Regulation of Akt Signaling and SERCA2}, journal={CJC Open}, year=2022, pages={1043-1052} }